These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24652455)

  • 1. An innovative hydrogel of gemcitabine-loaded lipid nanocapsules: when the drug is a key player of the nanomedicine structure.
    Moysan E; González-Fernández Y; Lautram N; Béjaud J; Bastiat G; Benoit JP
    Soft Matter; 2014 Mar; 10(11):1767-77. PubMed ID: 24652455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma.
    Bastiancich C; Vanvarenberg K; Ucakar B; Pitorre M; Bastiat G; Lagarce F; Préat V; Danhier F
    J Control Release; 2016 Mar; 225():283-93. PubMed ID: 26829100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug combination using an injectable nanomedicine hydrogel for glioblastoma treatment.
    Bastiancich C; Bozzato E; Luyten U; Danhier F; Bastiat G; Préat V
    Int J Pharm; 2019 Mar; 559():220-227. PubMed ID: 30703501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer-free hydrogel made of lipid nanocapsules, as a local drug delivery platform.
    Pitorre M; Gazaille C; Pham LTT; Frankova K; Béjaud J; Lautram N; Riou J; Perrot R; Geneviève F; Moal V; Benoit JP; Bastiat G
    Mater Sci Eng C Mater Biol Appl; 2021 Jul; 126():112188. PubMed ID: 34082987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection.
    Bastiancich C; Bianco J; Vanvarenberg K; Ucakar B; Joudiou N; Gallez B; Bastiat G; Lagarce F; Préat V; Danhier F
    J Control Release; 2017 Oct; 264():45-54. PubMed ID: 28830791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of lauroyl-gemcitabine-loaded hydrogel efficacy in glioblastoma rat models.
    Bastiancich C; Lemaire L; Bianco J; Franconi F; Danhier F; Préat V; Bastiat G; Lagarce F
    Nanomedicine (Lond); 2018 Aug; 13(16):1999-2013. PubMed ID: 30204064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aqueous-core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic response.
    Cosco D; Paolino D; De Angelis F; Cilurzo F; Celia C; Di Marzio L; Russo D; Tsapis N; Fattal E; Fresta M
    Eur J Pharm Biopharm; 2015 Jan; 89():30-9. PubMed ID: 25460850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy.
    Sasso MS; Lollo G; Pitorre M; Solito S; Pinton L; Valpione S; Bastiat G; Mandruzzato S; Bronte V; Marigo I; Benoit JP
    Biomaterials; 2016 Jul; 96():47-62. PubMed ID: 27135716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug delivery to tumours using a novel 5-FU derivative encapsulated into lipid nanocapsules.
    Lollo G; Matha K; Bocchiardo M; Bejaud J; Marigo I; Virgone-Carlotta A; Dehoux T; Rivière C; Rieu JP; Briançon S; Perrier T; Meyer O; Benoit JP
    J Drug Target; 2019; 27(5-6):634-645. PubMed ID: 30461322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules.
    Pinton L; Magri S; Masetto E; Vettore M; Schibuola I; Ingangi V; Marigo I; Matha K; Benoit JP; Della Puppa A; Bronte V; Lollo G; Mandruzzato S
    J Nanobiotechnology; 2020 Feb; 18(1):31. PubMed ID: 32066449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia.
    Briot T; Roger E; Lautram N; Verger A; Clavreul A; Lagarce F
    Int J Nanomedicine; 2017; 12():8427-8442. PubMed ID: 29200853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safe lipid nanocapsule-based gel technology to target lymph nodes and combat mediastinal metastases from an orthotopic non-small-cell lung cancer model in SCID-CB17 mice.
    Wauthoz N; Bastiat G; Moysan E; Cieślak A; Kondo K; Zandecki M; Moal V; Rousselet MC; Hureaux J; Benoit JP
    Nanomedicine; 2015 Jul; 11(5):1237-45. PubMed ID: 25791812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles.
    Chen Z; Zheng Y; Shi Y; Cui Z
    Int J Nanomedicine; 2018; 13():319-336. PubMed ID: 29391792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemcitabine-loaded liposomes: rationale, potentialities and future perspectives.
    Federico C; Morittu VM; Britti D; Trapasso E; Cosco D
    Int J Nanomedicine; 2012; 7():5423-36. PubMed ID: 23139626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new tool to ensure the fluorescent dye labeling stability of nanocarriers: a real challenge for fluorescence imaging.
    Bastiat G; Pritz CO; Roider C; Fouchet F; Lignières E; Jesacher A; Glueckert R; Ritsch-Marte M; Schrott-Fischer A; Saulnier P; Benoit JP
    J Control Release; 2013 Sep; 170(3):334-42. PubMed ID: 23792117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biocompatible Glycopolymer Nanocapsules via Inverse Miniemulsion Periphery RAFT Polymerization for the Delivery of Gemcitabine.
    Utama RH; Jiang Y; Zetterlund PB; Stenzel MH
    Biomacromolecules; 2015 Jul; 16(7):2144-56. PubMed ID: 26027950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo anti-tumor effects of gemcitabine loaded with a new drug delivery system.
    Tong Q; Li H; Li W; Chen H; Shu X; Lu X; Wang G
    J Nanosci Nanotechnol; 2011 Apr; 11(4):3651-8. PubMed ID: 21776750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioblastoma-targeted, local and sustained drug delivery system based on an unconventional lipid nanocapsule hydrogel.
    Gazaille C; Bozzato E; Madadian-Bozorg N; Mellinger A; Sicot M; Farooq U; Saulnier P; Eyer J; Préat V; Bertrand N; Bastiat G
    Biomater Adv; 2023 Oct; 153():213549. PubMed ID: 37453243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy.
    Khare V; Singh A; Mahajan G; Alam N; Kour S; Gupta M; Kumar A; Singh G; Singh SK; Saxena AK; Mondhe DM; Gupta PN
    Eur J Pharm Sci; 2016 Sep; 92():183-93. PubMed ID: 27404580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan-Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study.
    Hosseinzadeh H; Atyabi F; Dinarvand R; Ostad SN
    Int J Nanomedicine; 2012; 7():1851-63. PubMed ID: 22605934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.